Current Issue 2011, Vol. 22, No. 4

Issue Highlights

Expert Perspectives

  • The Role of PARP Inhibitors in Breast Cancer
    2011(Vol. 22 | No. 4 | Pages 341-343)

    Karen A. Gelmon

  • Circulating Tumor Cells: Prognosis, Prediction, and the Liquid Biopsy
    2011(Vol. 22 | No. 4 | Pages 344-346)

    Minetta C. Liu

  • Overview of Hypofractionation in Breast Radiotherapy
    2011(Vol. 22 | No. 4 | Pages 346-349)

    Navita Somaiah, John Yarnold

Currently, there are no articles still in press. The most recently published articles may be viewed from the Current Issue. New articles are added as soon as they are available so check back later.

On the Cover

Cover Image

New Issue Alert

Publishing Information

Breast Diseases: A Year Book Quarterly is published by Elsevier for the American Society of Breast Disease.



Access this journal onSciVerse ScienceDirect
Print or Share This Page

Journal Access

The site now contains additional features and a new look-and-feel. Full-text articles and abstracts are available to ASBD members and personal subscribers starting from 1999 to the present; abstracts, references, and PDFs are available from 2005. Access to abstracts is complimentary.

Already have a username and password?
Click here to log in.

First-time User?
Create an account here.

Subscribe to the journal now!

About the Journal

With more than 180,000 new cases of breast cancer diagnosed each year in the United States, specialists in many major medical disciplines-including surgery, obstetrics/gynecology, oncology, radiation therapy, diagnostic radiology, and medical management- will benefit from insightful and up-to-date information in Breast Diseases: A Year Book Quarterly.

About ASBD

The American Society of Breast Disease is the only medical society in the United States to advocate a multidisciplinary team approach as the standard of excellence in managing benign and malignant breast conditions. The ASBD provides professional education and advanced training in breast disease and cancer prevention, early detection, treatment, and survivorship.